Approval · Notice of Compliance 33982 · 2024
FRUZAQLA: Notice of Compliance 33982
Issued September 10, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33982
- Date
- September 10, 2024
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- FRUQUINTINIB 1 MG per CAP
- FRUQUINTINIB 5 MG per CAP